Compare OGN & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | NOMD |
|---|---|---|
| Founded | 1923 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2020 | 2015 |
| Metric | OGN | NOMD |
|---|---|---|
| Price | $9.69 | $9.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $11.75 | ★ $12.50 |
| AVG Volume (30 Days) | ★ 6.4M | 1.2M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | 0.86% | ★ 7.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | N/A |
| Revenue Next Year | $1.67 | $1.45 |
| P/E Ratio | $12.94 | ★ $8.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $9.43 |
| 52 Week High | $13.25 | $20.13 |
| Indicator | OGN | NOMD |
|---|---|---|
| Relative Strength Index (RSI) | 76.35 | 42.07 |
| Support Level | $8.63 | $9.49 |
| Resistance Level | $10.10 | $10.02 |
| Average True Range (ATR) | 0.58 | 0.23 |
| MACD | 0.42 | 0.07 |
| Stochastic Oscillator | 96.66 | 50.85 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.